Mkt Cap $583M
52-Week Range
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
Revenue is primarily driven by Product (76.3%) and Service (23.7%).
Most recently: and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), (2026-02-26).
$583M
Market Cap
$202M
Revenue
-$67M
Net Income
Revenue by Segment
Revenue by Geography